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The differentiation of the three primary germ layers is precisely regulated by inductive cues, the 
intracellular networks through which these signals are transduced, and a broad array of nuclear 
proteins, such as transcription factors and epigenetic modifiers. Precise regulation of these various 
factors is crucial to proper development. Members of the T-box family of DNA-binding proteins 
play a prominent role in the differentiation of the three primary germ layers. VegT, Brachyury, 
and Eomesodermin function as transcriptional activators, are expressed in the presumptive 
mesendoderm and, in addition to directly activating the transcription of endoderm- and mesoderm-
specific genes, serve variously as regulators of growth factor signaling during induction of these 
germ layers. In contrast, expression of the T-box gene tbx2 is present in the embryonic ectoderm, 
where Tbx2 functions as a transcriptional repressor and inhibits mesodermal and endodermal 
differentiation by the TGFβ ligand Activin. Notably, Tbx2 misexpression also promotes dorsal 
ectodermal fate via inhibition of the BMP branch of the TGFβ signaling network. We report here 
that Tbx2 physically associates with both Smad1 and Smad2, mediators of BMP and 
Activin/Nodal signaling, respectively. We perform structure function analysis of Tbx2 to elucidate 
the roles of both Tbx2-Smad interaction and Tbx2-DNA binding in germ layer suppression. Our 
studies demonstrate that Tbx2 associates with intracellular mediators of the Activin/Nodal and 
BMP/GDF pathways, crucial factors in germ layer patterning and differentiation. We have 
identified a novel repressor domain within Tbx2, and have determined that Tbx2 DNA-binding 
activity is required for repression of TGFβ signaling. Protein- protein interaction assays suggest 
that Tbx2-mediated repression involves an epigenetic mechanism. Finally, our data also point to 
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1 Chapter I: General introduction 
 
1.1 Introduction  
Understanding the development of an embryo from a single totipotent cell to a highly 
differentiated, multicellular organism is a foundational concern of developmental biology. In 
triploblasts, three embryonic germ layers, ectoderm, mesoderm, and endoderm, give rise to 
virtually all tissue types. The endodermal germ layer differentiates into pancreas, liver, lung, and 
other components of the digestive and respiratory systems. The mesodermal layer gives rise the 
muscular, circulatory, and skeletal systems, and the epidermis, neural tissue, neural crest, and 
cranial sensory placodes derive from ectoderm. The precise coordination of germ layer 
differentiation is, by definition, crucial for normal embryogenesis. In order to study development 
in vivo, I use the model organism Xenopus laevis. 
1.2 X. laevis as a model organism 
X. laevis is an excellent model for studying early development because their embryos are large, 
easy to visualize, and well suited for micro-dissections and microinjection of exogenous 
biomaterials. During X. laevis development, the formation and patterning of the three embryonic 
germ layers is a rapid and tightly regulated process. The germ layers in a developing embryo give 
rise to almost all tissue types; therefore, precise coordination of signaling networks that regulate 
differentiation of these germ layers is crucial. How an embryo develops from a single totipotent 
cell to a highly differentiated, multicellular organism is a subject of intense scrutiny. Several key 
biological processes that occur in cells during early stages of development in vivo are, in several 
respects, similar to the mechanisms by which embryonic cells can be maintained in a stem-like 
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state in vitro. In fact, many transcription factors that are responsible for controlling cell fate 
commitment in developing embryos also regulate development of pluripotent stem cells 
(Takahashi and Yamanaka, 2006). Therefore, identifying transcription factors necessary for germ 
layer differentiation has far-reaching implications for the fields of both developmental biology and 
regenerative medicine.  
 
X. laevis is used extensively to study development. Fertilization and development in X. laevis is 
external, and can therefore be easily visualized and studied. Following fertilization, rapid mitotic 
divisions result in a solid ball of cells called a morula. Subsequent cell divisions give rise to a 
blastula, a mass of cells surrounding a fluid-filled cavity called the blastocoel. During these 
developmental stages, the embryo contains maternally-supplied proteins and transcripts; little to 
no zygotic transcription occurs (Skirkanich et al., 2011). Once a specific nuclear to cytoplasmic 
volume ratio is reached, twelve rounds of cell division after fertilization, the mid-blastula transition 
(MBT) occurs (Jevtić and Levy, 2017). The MBT marks a number of changes in the embryo: cell 
divisions become slower and asynchronous. Additionally, during this transition the embryo begins 
to transcribe the zygotic genome. As soon as zygotic transcription occurs, the embryo begins to 
generate components of major signaling networks that are necessary for gastrulation (Heasman, 
2006).  
1.3 Gastrulation- germ layer formation and patterning 
In the amphibian embryo, gastrulation initiates when VegT, a maternally supplied factor, 
stimulates expression of transcription factors, such as Bix4, to specify cells located in the vegetal 
pole to differentiate into endoderm (Figure 1.1) (Casey et al., 1999; Horb and Thomsen, 1997; 
Xanthos et al., 2001). VegT also activates nodal and nodal-related gene expression; these 
transcripts encode proteins that induce cells in the region above the vegetal pole, called the 
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marginal zone, to differentiate as mesoderm (Figure 1.1) (Kofron et al., 1999; Xanthos et al., 
2001). The induction of mesoderm via the Activin/Nodal signaling pathway is known to be 




Figure 1-1 Diagram of X. laevis embryo during early gastrulation 
During gastrulation the three primary germ layers, endoderm, mesoderm, and ectoderm, begin to 
differentiate. The vegetal pole refers to the lower hemisphere of the embryo and will give rise to 
the endoderm. The marginal zone refers to the equatorial region of the embryo between the animal 
and vegetal poles and will give rise to the mesoderm. The mesoderm contains a dorsal organizer 
region which secretes BMP antagonists. The animal pole refers to the upper hemisphere of the 
embryo which will give rise to the ectoderm. The drawing of the cavity in the animal hemisphere 
depicts the fluid-filled blastocoel. As described in the text of this thesis, foxI1e, along with many 
other germ layer-enriched factors, is expressed in the cells of the animal pole. chordin and 
goosecoid are expressed in the dorsal marginal zone. wnt8 is expressed ventrolaterally and 
brachyury is expressed throughout the marginal zone. vegT, an activator of nodal and nodal-like 
genes, is expressed in the cells of the vegetal pole. The genes mentioned here are used throughout 











Activin/Nodal signaling initiates when Nodal, Nodal-like, and other related Transforming Growth 
Factor  (TGFβ) ligands bind to the type II TGFβ receptors, which subsequently phosphorylate 
the type I receptors (Wylie and Heasman, 1997). The type I and type II receptors then form a 
heterotetrameric complex, containing two of each receptor type. The activated type I receptors 
phosphorylate the receptor-activated Smads (R-Smads), Smad2, and Smad3. Once 
phosphorylated, Smad2 and Smad3 form a heteromeric complex with Smad4. This complex then 
translocates from the cytoplasm to the nucleus and, along with many associated proteins such as 
FoxHI, CREB binding protein, and Mixer, mediates the transcription of target genes (Chen et al., 
1997; Germain et al., 2000; Topper et al., 1998). Immediate-early targets of the Smad2/Smad4 
complex include, among others, goosecoid and mix.2 (Chen et al., 1996; Germain et al., 2000; 
Howell and Hill, 1997; Liu et al., 2011). High levels of Activin/Nodal signaling specify an 
endodermal fate; lower levels of Activin/Nodal signaling specify a mesodermal fate (Gurdon et 
al., 1994; Gurdon and Bourillot, 2001; Schier et al., 1997).  
 
1.4 Additional pathways that specify mesoderm induction 
 
In addition to the Activin/Nodal TGFβ pathway, several additional pathways are integral to 
mesoderm induction and maintenance in the developing embryo. For example, Fibroblast Growth 
Factor (FGF) signaling is required for the maintenance of mesoderm during gastrulation (Amaya 
et al., 1993; Fletcher and Harland, 2008; Schulte-Merker and Smith, 1995). FGF and Brachyury 
function through an autocatalytic loop; FGF induces expression of brachyury, which in turn 
induces expression of eFGF (Kim et al., 1998). Brachyury, a T-box transcription factor, is an 
immediate-early response to mesoderm induction and functions as an activator to turn on 
additional mesodermal genes (Figure 1.1) (Kispert et al., 1995; Smith et al., 1991; Tada and Smith, 
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2000). Additionally, β-catenin stabilization is necessary for proper FGF signaling in the 
prospective mesoderm during gastrulation (Moon, 2005; Schohl and Fagotto, 2003).  
 
FGF induces mesoderm through various downstream signaling mechanisms. FGF signaling leads 
to phosphorylation of the ERK mitogen-activated protein kinase (MAPK) pathway, which 
subsequently leads to phosphorylation of P53 (Cordenonsi et al., 2007; Heasman, 2006). Once 
phosphorylated, P53 physically associates with phosphorylated Smad2 to induce the expression of 
mesodermal genes (Cordenonsi et al., 2003; Takebayashi-Suzuki et al., 2003). Studies in mouse 
and mammalian cell culture show that independent from P53 phosphorylation, ERK also activates 
expression of many factors critical for mesodermal maintenance (Ciruna and Rossant, 2001; Yang 
et al., 2003). For example, ERK induces expression of Egr1, a transcription factor that regulates 
expression of FGF target genes (Nentwich et al., 2009). 
 
1.5  Differentiation and patterning of ectoderm 
The cells of the ectoderm give rise to several distinct tissue types. Ventral ectoderm differentiates 
into epidermal tissue, while neural tissue forms from the dorsal ectoderm; cells at the border 
between these two populations develop into the sensory placodes and neural crest (Baker and 
Bronner-Fraser, 2001; Mancilla and Mayor, 1996). During development, Bone Morphogenetic 
Protein (BMP) signaling gradients regulate dorsal/ventral patterning of the mesoderm (Heasman, 
2006). BMP signaling has been shown to also be critical for ectodermal patterning (Wilson and 
Hemmati-Brivanlou, 1995). Studies have shown that an abundance of BMP4, a ligand that 
stimulates the BMP signaling pathway and is initially widely expressed throughout the blastula, 
ventralizes the ectoderm which then differentiates into epidermis (Wilson and Hemmati-
Brivanlou, 1995). The BMP signaling pathway increases the expression of many ventral-specific 
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transcription factors that specify a ventral fate (De Robertis and Kuroda, 2004; Onichtchouk et al., 
1996). For example, BMP4 is necessary and sufficient for the expression of the ventral-specific 
transcription factor, Vent2 (Onichtchouk et al., 1996). The Spemann organizer secretes multiple 
BMP antagonists that inhibit BMP signaling dorsally and allow dorsal ectodermal cells to adopt 
their “default” fate, neural tissue; when BMP signaling is inhibited throughout the prospective 
ectoderm, all ectodermal cells differentiate into neural tissue (Hawley et al., 1995; Hemmati-
Brivanlou and Thomsen, 1995; Lamb et al., 1993; Sasai et al., 1995; Weinstein and Hemmati-
Brivanlou, 1997). Classical studies suggest that the ectoderm forms because the cell population 
overlying the blastocoel does not receive inducing signals to differentiate into 
endoderm/mesoderm; i.e., Activin/Nodal signals do not diffuse beyond the blastocoel floor 
(Heasman, 2006; Lee et al., 2001). Recent work, however, has demonstrated that there are proteins 
expressed in the ectoderm necessary for active repression/restriction of mesodermal and 
endodermal fates. Below, I describe the function of these factors, in detail. Activity of these factors 
has been examined in various biological pathways. A list of factors with activity in one or more 
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 Blocks via ligand 
inhibition 
Bell et al., Development 
2003 
Bates et al., Development 
2013 
Ndp (Norrin) +  Blocks via ligand 
inhibition 
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Chang et al., Dev. Biol. 
2003 
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1997 
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2018 
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2011 
Ascl1  + Recruits HDAC1 Gao et al., Development 
2016 





1.6  TGFβ pathway inhibitors 
Several of the proteins identified as necessary for repression of mesoderm and/or endoderm in the 
ectoderm are inhibitors of the Activin/Nodal signaling pathway. One such inhibitor of 
mesendoderm expression in the ectoderm, Dand5 (Coco), belongs to the Cerberus/DAN/Gremlin 
superfamily. Members of this superfamily were originally identified as antagonists of BMPs 
(Bouwmeester et al., 1996; Hsu et al., 1998; Piccolo et al., 1999). The BMP signaling pathway, 
like the Nodal/Activin pathway, is a branch of the TGFβ signaling network; during development 
in triploblastic organisms, BMP signaling ventralizes the gastrula (Hayward et al., 2002; Piccolo 
et al., 1996; Schmidt et al., 1995; Suzuki et al., 1994; Weiss and Attisano, 2013). It was 
subsequently determined that some members of the Cerberus/DAN/Gremlin superfamily function 
as secreted inhibitors of both BMP and Activin/Nodal ligands, many of which are present in the 
endoderm and mesoderm (Bouwmeester et al., 1996; Hsu et al., 1998; Piccolo et al., 1999). In the 
ectoderm, Dand5 functions as a TGFβ ligand antagonist and, supplied maternally, is one of the 
earliest expressed antagonists of TGFβ signaling (Figure 1.2) (Bell et al., 2003). In animal cap 
explants, Dand5 physically associates with both BMP4 and Xnr1, ligands of the BMP and 
Activin/Nodal pathways, respectively (Bell et al., 2003; Rahman et al., 2015; Zhou et al., 1993). 
A population of pluripotent cells can be isolated from the animal pole of blastula stage X. laevis 
embryos; this explant, called an “animal cap,” can be induced to differentiate into various tissue 
types (Sive, 1993). Dand5 inhibits the mesoderm-inducing abilities of Xnr1 misexpression as well 
as the ventralizing effects of BMP4 misexpression (Bell et al., 2003). The knockdown of Dand5 
in animal caps leads to increased levels of phosphorylated Smad2 and increased expression of 
mesodermal markers (Bates et al., 2013). Loss of Dand5 in whole embryos leads to increased 
endodermal marker expression at the expense of mesoderm; the knockdown of dand5 in the 
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presumptive mesoderm causes a reduction of the dorsal marker chordin (Bates et al., 2013). Loss 
of Dand5 also leads to loss of Hoxb9, a spinal cord marker, suggesting the loss of Dand5 
ventralizes the embryo (Bates et al., 2013). Overall, these experiments demonstrate that Dand5 
inhibits both the BMP and Activin/Nodal branches of the TGFβ signaling pathway and is necessary 
for repression of inappropriate mesendodermal gene expression in the ectoderm during 
gastrulation (Bates et al., 2013; Bell et al., 2003). 
 
Figure 1-2 Extracellular regulation of mesendodermal gene expression. 
 In this and subsequent figures, red boxes denote mesendoderm inhibitors. R-Smads refer to 
Smads1/5/8 or Smads2/3 for the BMP and Activin/Nodal pathways, respectively. TGFβ ligands 
(BMP4 and Activin/Nodal) bind the TGFβ receptor complex and activate signal transduction of 
the TGFβ signaling pathway. Dand5 (Coco) and Ndp (Norrin) physically associate (independently 
from one another) with BMP and Activin/Nodal and inhibit signal transduction. 
 
At early cleavage stages, another maternal TGFβ ligand inhibitor, Ndp (Norrin), is expressed in 
the prospective ectoderm (Bates et al., 2013). Ndp is a secreted protein characterized by a cysteine-
knot motif and was initially shown to function as a ligand in the Wnt signaling pathway (Berger 
et al., 1992; Xu et al., 2004). Misexpression of ndp in animal caps represses Activin-mediated 
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mesendoderm induction, and promotes neural fate, suggesting a repression of BMP signaling (Xu 
et al., 2004). Co-immunoprecipitation experiments show that Ndp physically associates with the 
BMP pathway ligand, BMP4, and, in cell culture experiments, the Activin/Nodal pathway ligand, 
Xnr1 (Xu et al., 2004). These studies suggest that Ndp inhibits TGFβ signaling via association 
with TGFβ ligands (Figure 1.2). 
 
Another repressor of aberrant gene expression in the ectoderm is Tomoregulin-1 (TMEFF1), a 
transmembrane protein (Chang et al., 2003; Harms and Chang, 2003). Misexpression of TMEFF1 
suppresses Nodal- and Vg1- induced mesendoderm expression; TMEFF1 does not inhibit Activin-
induced mesendoderm (Chang et al., 2003). The association of Nodal with the type II and type I 
TGFβ receptors and subsequent phosphorylation of Smad2 depends on a Cripto family co-receptor 
(Yeo and Whitman, 2001). While important for signal transduction of the TGFβ pathway upon 
Nodal ligand binding, Cripto has not been implicated in Activin signaling (Yeo and Whitman, 
2001). Cripto physically associates with the TGFβ type I receptor and promotes the association of 
Nodal and the type I receptor. TMEFF1 inhibits Nodal signaling by physically associating with 
the type I co-receptor and preventing the type I co-receptor from forming a complex with Cripto, 




Figure 1-3 Transmembrane and cytosolic inhibition of mesendodermal gene expression. 
TMEFF1, a transmembrane protein, prevents the association between Cripto, a Nodal-pathway 
specific coreceptor, and the type I receptor. Smad7 inhibits TGFβ signaling by forming a complex 
with Smurf2, which subsequently induces the degradation of the type I and type II TGF receptors. 
BAMBI, another transmembrane protein, associates with Smad7 and the type I receptor and 
inhibits association between the type I receptor and R-Smads. The “X” indicates the lack of a 
serine/threonine intracellular kinase domain.  
 
An additional inhibitor of TFG signaling during early development is BMP and Activin 
Membrane-bound Inhibitor (BAMBI). BAMBI is a transmembrane protein with an extracellular 
domain that is similar to that of the BMP type I receptor but lacks an intracellular serine/threonine 
kinase domain (Onichtchouk et al., 1999). Misexpression of BAMBI in X. laevis animal caps is 
sufficient to repress the effects of both BMP4 and Activin treatment (Onichtchouk et al., 1999). 
BAMBI inhibits TGFβ signaling by associating with the type I and type II receptor complex 
(Figure 1.3) (Onichtchouk et al., 1999). BAMBI decreases the phosphorylation level of the type I 
receptor, and the homodimerization of type I receptors, necessary components of the TGFβ 
signaling pathway (Luo and Lodish, 1996). Cell culture experiments show that BAMBI promotes 
the formation of a ternary complex composed of Smad7, BAMBI, and the BMP type I receptor 
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(Figure 1.3) (Yan et al., 2009). In this case, BAMBI and Smad7 do not induce Smurf-mediated 
receptor degradation (Yan et al., 2009); instead, the Smad7-BAMBI-type I receptor complex 
inhibits the physical association between the type I receptor and R-Smads (Yan et al., 2009). 
 
Another identified mechanism of mesoderm repression is via Smad4 inhibition. Smad4, an 
intracellular mediator of TGFβ signaling, forms a heteromeric complex with Smad1/5/8 or 
Smad2/3 in the BMP and Activin/Nodal pathways, respectively. As a downstream mediator of 
both BMP and Activin/Nodal signaling, degradation of Smad4 inhibits signaling in both pathways 
(Lagna et al., 1996). In the ectoderm, Trim33 (Ectodermin), a RING-type ubiquitin ligase, 
physically associates with Smad4 (Figure 1.4) (Dupont et al., 2005). This association promotes the 
degradation of Smad4 (Dupont et al., 2005). Loss of Trim33 in the prospective marginal zone of 
X. laevis embryos expands the expression of endodermal markers, and loss of Trim33 in animal 
cap explants induces expression of mesodermal markers (Dupont et al., 2005). Misexpression of 
Trim33 in the prospective mesoderm represses mesodermal and ventral markers and increases the 
expression of neural markers (Dupont et al., 2005). These data show that Trim33 is necessary for 
inhibition of mesodermal and endodermal gene expression in the ectoderm. 
 
An additional potent inhibitor of TGFβ signaling is Smad7, an “anti-Smad” (Nakao et al., 1997). 
Misexpression experiments in X. laevis demonstrate that Smad7 is sufficient to reduce mesodermal 
markers in both the mesoderm and in Activin-treated animal cap explants (Casellas and Brivanlou, 
1998). Smad7 also inhibits the expression of ventral markers (Casellas and Brivanlou, 1998). This 
indicates that Smad7 suppresses the Activin/Nodal and BMP pathways during gastrulation 
(Casellas and Brivanlou, 1998; Nakao et al., 1997). Smad7 mediates this suppression through 
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inhibition of R-Smad phosphorylation by the TGF receptors (Nakao et al., 1997). The exact 
molecular mechanisms through which Smad7 inhibits TGFβ signaling have been demonstrated in 
cell culture experiments. Smad7 physically associates with Smurf2 via a PPXY sequence in its 
linker region. Smad7 regulates the localization of Smurf2; the Smurf2-Smad7 complex 
translocates from the nucleus to the cytosol where it associates with a heteromeric type I and II 
receptor complex (Figure 1.3) (Kavsak et al., 2000). Once associated with the TGFβ heteromeric 
complex, Smurf2 induces degradation of the TGFβ receptors via both proteasomal and lysosomal 
pathways (Kavsak et al., 2000). These data from cell culture experiments provide insight into how 
Smad7 may function to inhibit mesodermal and endodermal gene expression during gastrulation. 
Smad6, another anti-Smad, blocks BMP signaling in X. laevis (Hata et al., 1998; Imamura et al., 
1997; Onichtchouk et al., 1999). Studies in X. laevis have shown that smad6 overexpression 
partially inhibits Activin-mediated mesoderm induction; however, the exact mechanism of this 
repression is not well studied (Nakayama et al., 1998). 
 
Regulation of TGFβ signaling also occurs downstream of the Smad2-Smad4 complex. The serum 
response factor (SRF) belongs to the MADS-box family of transcription factors (Shore and 
Sharrocks, 1995). MADS-box transcription factors contain a conserved 56 amino acid MADS-box 
which confers DNA-binding activity (Shore and Sharrocks, 1995). During gastrulation, srf 
transcripts are present predominantly in the ectoderm of X. laevis embryos, with low levels 
detected in the marginal zone and no expression of SRF detected in the endoderm (Yun et al., 
2007). Loss-of-function studies demonstrate that SRF is necessary for the repression of 
mesodermal markers in the ectoderm. Expression of a dominant-negative form of SRF in animal 
cap explants of X. laevis embryos leads to ectopic expression of mesoderm (Shore and Sharrocks, 
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1995). The knockdown of SRF in whole embryos leads to an expansion of mesodermal markers 
towards the ectoderm (Shore and Sharrocks, 1995). An investigation into the mechanism of action 
of SRF revealed that SRF represses mesoderm in the developing embryo by inhibiting the 
association between Smad2 and Fast1 (Chen et al., 1997). Fast-1 (FoxH1) is a winged-helix 
transcription factor that physically associates with Smad2 and functions as a co-activator to 
positively regulate target genes (Chen et al., 1997, 1996). Through this mechanism, SRF functions 
in the ectoderm to limit mesendoderm expression (Figure 1.4) (Yun et al., 2007).  
 
 
Figure 1-4 Nuclear regulation of mesendodermal gene silencing. 
Trim33 (Ectodermin) functions in the nucleus and, via ubiquitination, promotes the degradation of 
Smad4. At the transcriptional level, SRF prevents association between FoxH1 and the Smad2-
Smad4 complex, repressing Smad2 target genes. Eaf1/2 are repressors that inhibit Activin-
mediated mesoderm induction via P53-dependent and P53-independent mechanisms. Eaf1/2 
physically associate with P53, Smad2, Smad3, and FoxH1. ZNF585B (XFDL156) reduces the 
amount of P53 bound to P53 target sites and represses P53-mediated mesodermal gene expression. 
FoxI1e is an activator that likely indirectly inhibits mesendodermal gene expression in the 
ectoderm. Tbx2, a T-box transcription factor, also represses mesendodermal gene expression. 
Geminin is a chromatin modifier that represses gene expression by recruiting the PRC2 complex. 
The PRC2 complex then trimethylates H3K27 to silence gene expression. Ascl1, another 






Initially identified as tumor suppressors, Eaf1/2 have also been shown to inhibit phosphorylated 
Smad2 activity during germ layer specification (Liu et al., 2017; Xiao et al., 2003). Eaf1/2 are 
ELL-associated factors that were initially shown to function as antagonists of Wnt/β-catenin 
signaling during development (Liu et al., 2013). During embryogenesis, Wnt/β-catenin plays an 
important role in establishing the dorsoventral and anteroposterior axes of the embryo (Hikasa and 
Sokol, 2013). Consistent with this, misexpression experiments in zebrafish demonstrate that 
Eaf1/2 increase dorsal markers during gastrulation (Liu et al., 2013). Eaf1/2 function as 
transcriptional repressors to inhibit Wnt/β-catenin signaling (Liu et al., 2013). Eaf1/2 were later 
studied for their role in germ layer specification during gastrulation. Misexpression of Eaf1/2 
reduces the expression of mesodermal and endodermal markers in zebrafish embryos. Loss of 
function experiments show that the ectodermal marker foxi1 decreases in eaf1/2 morphants (Liu 
et al., 2017). Studies in cell culture show that Eaf1/2 co-localize and physically associate with 
Smad2. Chromatin immunoprecipitation experiments reveal that Eaf1/2 occupy promoters of 
TGFβ targets, suggesting that Eaf1/2 function as transcriptional repressors, as they function in the 
Wnt/β-catenin pathway, to repress the mesoderm-inducing activities of the Activin/Nodal branch 
of the TGFβ signaling pathway, and specifically the function of Smad2 (Figure 1.4) (Liu et al., 
2017).  
1.7 P53 inhibitors in mesoderm repression 
P53 has been shown to induce mesoderm when overexpressed in animal cap explants of X. laevis 
embryos; phosphorylated P53 physically associates with phosphorylated Smad2 to activate 
mesodermal marker expression (Cordenonsi et al., 2007; Takebayashi-Suzuki et al., 2003). 
Knockdown of P53 in eaf1/2 morphant zebrafish embryos reduces levels of mesodermal marker 
expression, suggesting that Eaf1/2 may partially suppress mesodermal markers through a P53-
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dependent mechanism (Liu et al., 2017). However, Eaf1/2 are still able to repress TGFβ targets 
whose induction is independent of P53 function: Eaf1/2 suppress P53-independent targets of TGFβ 
signaling in P53 mutant embryos (Liu et al., 2017). Studies also show that Eaf1/2 physically 
associate with P53 and suppress Activin-induced luciferase activity downstream of P53 response 
elements and P53-required TGFβ Luciferase reporters (Figure 1.4) (Liu et al., 2017). These data 
suggest that Eaf1/2 function at the transcriptional level to repress P53-mediated mesoderm 
induction (Liu et al., 2017). 
 
Another inhibitor of P53-induced mesoderm expression is ZNF585B (XFDL156). ZNF585B is a 
zinc finger nuclear factor present in X. laevis embryos in the ectoderm during early gastrulation 
(Sasai et al., 2008). Misexpression experiments in animal cap explants reveal that ZNF585B 
specifically represses mesodermal, and not endodermal, marker expression, suggesting that 
ZNF585B does not function as a TFGβ pathway signaling inhibitor (Sasai et al., 2008). This led 
to the discovery that ZNF585B functions as a P53 inhibitor; it physically associates with P53 and 
decreases the level of P53 binding to target promoter sites (Figure 1.4) (Sasai et al., 2008). The C-
terminus of P53 is referred to as the regulatory domain (RD); removal of this domain increases the 
mesoderm-inducing ability of P53 (Cordenonsi et al., 2003; Takebayashi-Suzuki et al., 2003). The 
deletion of the RD reduced the ability of ZNF585B to effectively inhibit mesoderm induction via 
P53, indicating that the P53 RD is necessary for ZNF585B suppressor activity (Sasai et al., 2008). 
 
1.8 Epigenetic suppressors of mesendoderm 
In addition to the TGFβ pathway inhibitors and transcription factors described above, epigenetic 
modifiers have been implicated in mesoderm and endoderm suppression. Geminin, a nuclear 
protein, was initially identified as a regulator of DNA replication (McGarry and Kirschner, 1998). 
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During gastrulation, Geminin promotes the expression of neural markers at the expense of 
epidermal markers (Kroll et al., 1998). Misexpression of geminin suppressed both mesodermal and 
endodermal markers in Activin- and FGF- treated animal cap explants. (Lim et al., 2011). The 
knockdown of Geminin expands the expression patterns of mesodermal and endodermal genes; 
however, the knockdown of Geminin in the animal pole of whole embryos is insufficient to induce 
expression of mesodermal and endodermal markers (Lim et al., 2011). Geminin has been shown 
to repress transcription through the Polycomb Repressive Complex 2 (PRC2); PRC2 is a cluster 
of proteins that act as an epigenetic modulator to suppress transcription and has been implicated 
in many biological processes including cell fate determination (Figure 1.4) (Margueron and 
Reinberg, 2011; Schwartz and Pirrotta, 2013). Specifically, PRC2 functions as a methyltransferase 
to trimethylate H3K27 and repress transcription (Cao et al., 2005). PRC2 is comprised of the 
proteins Ezh2, Suz12, and Eed (Laugesen et al., 2016). Knockdown of either Suz12 or Ezh2 
inhibits the repressive effects of Geminin misexpression, suggesting that an intact PRC2 is 
necessary for Geminin function (Lim et al., 2011).  
 
Another chromatin modifier implicated in repression of inappropriate gene expression in the 
ectoderm is Ascl1. Ascl1 has been shown to neuralize mouse embryonic fibroblasts (Wapinski et 
al., 2013). In X. laevis, Ascl1 inhibits VegT-mediated mesendoderm induction, but not 
Activin/Nodal-mediated mesoderm induction. During gastrulation, VegT directly activates various 
Nodal-related mesendoderm inducers (Clements et al., 1999; Heasman, 2006). Ascl1 is expressed 
maternally, and during gastrulation is detected at high levels in the ectoderm and at lower levels 
in the marginal zone (Gao et al., 2016). Experiments in both mammalian cell culture and X. laevis 
embryos reveal that Ascl1 functions to recruit HDAC1 to reduce H3K27 acetylation, a marker of 
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actively transcribed promoters (Figure 1.4) (Gao et al., 2016; Tie et al., 2009). Microinjection of 
VegT increases levels of H3K27ac and H3K9ac (also a hallmark of active promoters) on 
mesodermal and endodermal genes such as Nodal, and these levels are reduced by misexpression 
of Ascl1 (Gao et al., 2016; Gates et al., 2017; Tie et al., 2009). 
 
1.9 Additional transcriptional regulators of inappropriate germ layer 
expression 
The transcription factor, FoxI1e (Xema) is required for the suppression of mesendodermal 
expression in the ectoderm during gastrulation (Figure 1.4) (Suri et al., 2005). The Fox 
transcription factors are characterized by a conserved winged-helix DNA-binding domain, and 
many are present during early embryogenesis (Pohl and Knöchel, 2005). Misexpression of FoxI1e 
represses both Activin and FGF-mediated mesoderm induction, suggesting that FoxI1e may not 
act directly, or at least not only, as a TGFβ pathway inhibitor (Suri et al., 2005). FoxI1e functions 
as a transcriptional activator during early development (Suri et al., 2005). Expression of a chimeric 
protein consisting of the FoxI1e coding region fused to an Engrailed repressor domain induces 
mesodermal marker expression in animal cap explants, suggesting that repression of FoxI1e 
transcriptional targets is sufficient to induce mesoderm (Suri et al., 2005). Misexpression of FoxI1e 
in the endoderm induces the expression of both epidermal and neural ectodermal markers (Mir et 
al., 2007). FoxI1e also plays a role in the spatial regulation of ectodermal cells: loss of FoxI1e 
causes ectodermal cells to lose adhesive properties and relocate to other germ layers (Mir et al., 
2007). 
 
As a transcriptional activator, it is likely that FoxI1e suppresses mesoderm indirectly, possibly 
through activation of a transcriptional repressor responsible for suppressing mesodermal and 
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endodermal gene expression in the ectoderm. tbx2, a gene encoding a T-box family transcription 
factor, has been identified as a target of FoxI1e (Figure 1.4) (Teegala et al., 2018). The structure 
of T-box proteins is conserved across five subfamilies (Papaioannou, 2014). All T-box proteins 
contain a highly conserved region of 180–200 amino acids, called the T-box, which confers DNA-
binding specificity (Wilson and Conlon, 2002). T-box proteins can function as activators or 
repressors of transcription (Plageman and Yutzey, 2005; Zaragoza et al., 2004). Like foxi1e, tbx2 
is expressed at high levels in the animal pole during gastrulation (Teegala et al., 2018). Also, like 
FoxI1e, Tbx2 represses Activin and FGF-mediated mesoderm induction (Teegala et al., 2018). 
However, unlike FoxI1e, Tbx2 functions as a transcriptional repressor (Teegala et al., 2018). 
Misexpression experiments show that Tbx2 also represses ventral fate in animal cap explants and 
induces expression of the “default” dorsal fate—neural tissue (Hemmati-Brivanlou and Melton, 
1994, 1992; Teegala et al., 2018; Weinstein and Hemmati-Brivanlou, 1997). Ectopic expression 
of Tbx2 in the marginal zone represses mesodermal and ventral markers (Reich et al., 2020). To 
further demonstrate the repressive effect of Tbx2, the promoter region of bix4, a target of the T-
box transcription factors Brachyury and VegT, was fused to a Luciferase reporter gene. Bix4-
promoter/Luciferase experiments suggest that Tbx2 requires the T-box sites on the Bix4 promoter 
for repression (Teegala et al., 2018). The ability of tbx2 to repress both BMP and Activin/Nodal 
pathways suggests that Tbx2 may function through the TGFβ pathway and/or TGFβ target gene 
inhibition; however, the ability of Tbx2 to repress FGF-mediated mesoderm induction suggests 
that Tbx2 may additionally repress transcription through TGFβ-independent mechanisms. In this 







Vertebrate germ layer formation and patterning is a complex process that involves both the 
activation and suppression of multiple signaling pathways. Highlighted in this introduction are 
several inhibitors of TGFβ signaling, necessary for repression of mesendodermal gene expression 
in the presumptive ectoderm. These antagonists function at many steps in the pathway, from 
ligand-receptor complex formation to TGFβ-mediated regulation of transcription. The requirement 
for additional transcriptional repressors and chromatin modifiers demonstrates that inhibition at 
multiple network nodes is necessary to restrict mesendoderm during gastrulation.  
 
The restriction of mesendodermal gene expression in the animal pole and inhibition of BMP 
signaling in the dorsal ectoderm during early development are sufficient to give rise to neural 
tissue. These instances of gene repression are examples of a common theme found throughout 
developmental biology, whereby localized inhibition of gene expression within the developing 
embryo gives rise to “zones of plasticity” allowing distinct cell fates to arise. A somewhat 
analogous process occurs during early post-implantation stages of mouse development. Initially 
nodal is expressed throughout the epiblast and is necessary for proximal-distal patterning (Brennan 
et al., 2001). Subsequently, during gastrulation, the anterior epiblast, fated to become ectoderm, 
exhibits little Nodal signaling due to localized repression by multiple extracellular Nodal 
antagonists (Tam et al., 2006). Studies in cell culture show that inhibition of Nodal signaling 
specifies a transient ectodermal progenitor population that can give rise to either neural or 
epidermal ectodermal fates (Li et al., 2015). This introduction highlights the process by which 
multiple factors, via inhibition at multiple signaling nodes, specify a region devoid of 
mesendoderm-inducing and ventralizing signals during gastrulation. In this thesis I will explore 
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the mechanisms through which Tbx2 inhibits mesendoderm-inducing and ventralizing signals in 





2 Chapter II Materials and Methods 
 
2.1 RNA preparation, explant dissection, and embryo culture 
RNA was synthesized in vitro in the presence of cap analog using the mMessage mMachine kit 
(Ambion). Microinjection, explant dissection, and embryo culture were performed as described 
(Li et al., 2015). All constructs were injected at a concentration of 1ng/embryo except in the 
experiments with tbx2NS1T or where indicated in the figure legend. For all animal cap and marginal 
zone explant experiments, a minimum of five explants was used for each condition, and each 
experiment was performed at least three times; results were consistent between all trials. 
 
2.2  Construct preparation  
To generate Myc-Tbx2ΔC, six Myc epitope tags were added upstream of a Tbx2ΔC construct, the 
latter containing amino acids 1-518 of Tbx2 (Cho et al., 2011; Teegala et al., 2018). To generate 
Tbx2ΔN, amino acids 54-688 were subcloned into pCS2++. For the Myc-Tbx2ΔN, DNA encoding 
amino acids 54-688 were subcloned into pCS2MT (constructed by D. L. Turner and R. A. W. 
Rupp).To generate Tbx2S1T-noNLS, DNA encoding amino acids 54-279 was subcloned into 
pCS2++. To generate Myc-Tbx2S1T-noNLS, the same sequence was subcloned into pCS2MT. For 
Tbx2NS1T, amino acids 290-688 were deleted from Tbx2 in pCS2+. The same amino acids were 
deleted from Myc-Tbx2 to generate Myc-Tbx2NS1T (Genewiz). In this construct and all 
subsequent constructs with the Tbx2 T-box at the C terminus, ten amino acids from spacer 2 were 
added to include the nuclear localization sequence (Carlson et al., 2001). To generate Tbx2TS2C, 
amino acids 1-54 were deleted from Tbx2 in pCS2+. The same amino acids were deleted in Myc-
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Tbx2 to generate Myc-Tbx2TS2C (Genewiz). To construct Tbx2S1T and Myc-Tbx2S1T, amino 
acids 290-688 were deleted from Tbx2ΔN and Myc-Tbx2ΔN, respectively. Myc-Tbx2R-A was 
generated by a single amino acid mutation of Arginine 122 to Alanine (AGG to GCT) in Myc-
Tbx2 (Genewiz) (Sinha et al., 2000). Flag-Smad2 was purchased from Addgene (plasmid #14042). 
Flag-Smad4 was a gift from Dr. Gerald Thomsen (Kavsak et al., 2000). Tbx2-DBD-VP16 was 
previously described (Teegala et al., 2018). To generate Flag-tagged H2A constructs, Flag-tagged 
hH2A was subcloned into the pCS2++ vector from pCDNA3.1-Flag-H2A (Flag-hH2A) (Mattiroli 
et al., 2012). To generate Flag-xH2A, Flag-xH2A.X, and Flag-xH2A.Z, the sequence for hH2A 
was removed from Flag-hH2A and replaced with sequences for xH2A, xH2A.X, or xH2A.Z (Flag-
xH2A, Flag-xH2A.X, Flag-xH2A.Z). In all H2A constructs, the “h” and “x” refers to human and 
X. laevis, respectively. The nucleotide sequences for each of these H2A constructs were 
synthesized de novo and inserted in frame with the Flag tag (Genscript). To generate HA-tagged 
H2A constructs, the Flag tag was removed from Flag-xH2A, Flag-xH2A.X, and Flag-xH2A.Z 
constructs and replaced with an HA-tag (HA-xH2A, HA-xH2A.X, HA-xH2A.Z, respectively) 
(Genscript). 
 
2.3 Cycloheximide assays 
X. laevis embryos were injected at the two-cell stage with 1ng of tbx2-DBD-Vp16. Animal caps 
were explanted at stage 8 and incubated in 10ug/ml of cycloheximide until early gastrula stages. 
Animal cap explants were then harvested and RNA was extracted in preparation for RT-PCR. 




2.4 Reverse transcription-polymerase chain reaction (RT-PCR) 
X. laevis embryos were staged according to Nieuwkoop and Faber, 1967 and harvested at 
appropriate stages according to morphological criteria. RNA was prepared using RNA Bee RNA 
isolation reagent (Tel-Test Inc.). RT-PCR was performed as described (Wilson and Hemmati-
Brivanlou, 1995). All primer sequences are as described: ODC, Xbra, Wnt8, chordin, and 
goosecoid (Suri et al., 2005); sizzled1 (Sridharan et al., 2012); sizzled2 (Jin and Weinstein, 2018); 
bmp4 (Fainsod et al., 1997); Xvent2 (Miyazaki et al., 2012); bix4 (Teegala et al., 2018); derriere 
(Sun et al., 1999); Xwnt11 (Afouda and Hoppler, 2011). 
 
2.5 Western blot analysis 
Western blot analysis was performed largely as described (Hama et al., 2002). Animal caps (10-
15 per condition) were lysed in 5ul/animal cap of lysis buffer (150mM NaCl, 20mM Tris pH 7.5, 
1% Nonidet P-40, 1mM EDTA, and 1 protease and phosphatase inhibitor tablet/10 ml of buffer) 
(Thermofisher) (Hama et al., 2002). After incubation on ice for 30 minutes, animal cap lysates 
were centrifuged at 4°C for 5 minutes at 14,000g. Clear supernatant was retained. 5-15 ul of 
supernatant was run for each sample. Antibodies against phospho-Smad1/5 (S463/465) (Cell 
Signaling Technology), Smad1 (Cell Signaling Technology), Phospho-Smad2 (S465/467) (Cell 
signaling technology), Smad2/3 (Cell signaling technology) and GAPDH (Sigma) were all used at 
1:1000 dilution. Secondary antibodies (donkey anti-rabbit IgG, or donkey anti-mouse IgG) 
coupled to horseradish peroxidase (Jackson ImmunoResearch) were used at 1:10,000 dilution. 





RNA from all Myc-tagged constructs was injected into early cleavage stages embryos. Injected 
embryos were harvested at late gastrula stages. Co-immunoprecipitation experiments were 
performed largely as described (Hama et al., 2002). Embryos were lysed in 10ul/embryo of lysis 
buffer (150mM NaCl, 20mM Tris pH 7.5, 1% Nonidet P-40, 1mM EDTA, and 1 protease inhibitor 
tablet/10 ml of buffer) (Thermofisher) (Hama et al., 2002). After incubation on ice for 30 minutes, 
embryo lysates were centrifuged at 4°C for 5 minutes at 14,000g. Clear supernatant was retained 
and then split equally into control and experimental samples. 10 ul of clear supernatant was 
removed as “input” from each sample. Embryo lysates were incubated with rotation overnight at 
4°C with either anti-Smad1 (333 µg/ml), anti-Flag (800 µg/ml), or anti-Myc (7.4mg/ml) antibodies 
at 1:150 dilution, normal Rabbit IgG (1 mg/ml) with the IgG normalized to experimental samples 
and Mouse IgG1 (2.5mg/ml) with the IgG1 normalized to experimental samples) (Cell Signaling 
Technology), followed by incubation with Dynabeads Protein G (Novex) with rotation at 4°C for 
one hour. Samples were washed 6 times with 200 ul of lysis buffer and eluted with 20ul of 1X 
NuPage LDS sample buffer and 5ul of .5M dithiothreitol. The elution was subject to SDS-PAGE. 
Antibodies against Myc (Sigma), Flag (Sigma), HA (Cell Signaling), and Smad1 (Cell Signaling) 
were used to probe the blot at 1:1000 dilution. Secondary antibodies (donkey anti-mouse IgG or 
donkey anti-rabbit IgG) coupled to horseradish peroxidase (Jackson ImmunoResearch) were used 
at 1:10,000 dilution. 
2.7 Immunoprecipitation-mass spectrometry 
 
210 embryos were injected in the animal pole at early cleavage stages, each with 1ng of myc-
Tbx2 and collected at mid-gastrula stages. Myc-Tbx2 was immunoprecipitated with an anti-Myc 
antibody (Sigma-Aldrich) or an IgG1 control antibody (Cell Signaling). The samples were sent to 
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MS Bioworks and run on an SDS-PAGE gel. Bands were excised and analyzed by nano-liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). Proteins were identified by Mascot 





3 Chapter III: Tbx2 mediates dorsal patterning and germ layer 
suppression through inhibition of BMP/GDF and Activin/Nodal 
signaling 
 
3.1  Introduction 
T-box proteins are an evolutionarily conserved family of transcription factors critical for a number 
of processes during development (Showell et al., 2004). The first identified T-box protein, T, 
encoded by brachyury, induces mesoderm in the early mammalian embryo (Kispert et al., 1995). 
In the mouse, a homozygous loss-of-function mutation in brachyury is embryonically lethal, 
highlighting the importance of T-box proteins in early development (Gluecksohn-Schoenheimer, 
1938). T-box proteins have also been implicated in development of craniofacial tissue, liver, heart, 
and lung (Christoffels et al., 2004; Dastjerdi et al., 2007; Lüdtke et al., 2013, 2009; Xanthos et al., 
2001). 
 
The T-box proteins are comprised of five subfamilies; all contain a highly conserved region of 
180-200 amino acids, called the T-box, which confers DNA binding specificity (Papaioannou, 
2014; Wilson and Conlon, 2002). Many T-box proteins have been shown to bind the core T-box 
binding element TCACACCT (Wilson and Conlon, 2002). T-box proteins bind to DNA as either 
monomers or dimers, depending on the protein, and can function as activators or repressors of 
transcription (Conlon et al., 2001). Activator and repressor domains have been identified in the 
carboxyl (C)- or amino (N)- termini of T-box proteins (Plageman and Yutzey, 2005; Zaragoza et 
al., 2004).  
 
Two well-studied T-box proteins, Brachyury, mentioned above, and VegT, mentioned previously, 
are necessary for formation and patterning of mesoderm and endoderm, respectively; both function 
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as transcriptional activators in this context (Herrmann et al., 1990; Xanthos et al., 2001). Our lab 
has recently shown that Tbx2 functions in the ectoderm as a transcriptional repressor during 
gastrulation (Teegala et al., 2018). When tbx2 is knocked down in the presumptive ectoderm, 
ectopic mesendoderm--a transient, precursor cell population from which both mesoderm and 
endoderm emerge during gastrulation-- forms (Charney et al., 2017). Moreover, ectopic Tbx2 
suppresses mesendoderm in animal cap explants exposed to Activin or basic Fibroblast Growth 
Factor (bFGF) (Teegala et al., 2018). To date, however, little is known about the mechanisms 
through which Tbx2 promotes mesendoderm repression. 
 
The population of cells in the ectoderm develops into several distinct tissue types. Ventral 
ectoderm differentiates into epidermis, while the dorsal ectoderm gives rise to neural tissue 
(Wilson and Hemmati-Brivanlou, 1995); cells at the border of these two populations develop into 
the sensory placodes and neural crest (Baker and Bronner-Fraser, 2001; Mancilla and Mayor, 
1996). Bone Morphogenetic Protein-4 (BMP-4), expressed throughout the ectoderm, ventralizes 
the ectoderm, which subsequently differentiates into epidermis (Weinstein and Hemmati-
Brivanlou, 1997). Dorsally, at the initiation of gastrulation, the Spemann organizer secretes BMP 
antagonists allowing proximal ectodermal cells to adopt a dorsal, neural fate (Weinstein and 
Hemmati-Brivanlou, 1997). Tbx2 misexpression also dorsalizes ectoderm, resulting in 
neuralization; this effect is accompanied by downregulation of Bone Morphogenetic Protein 
(BMP) activity (Teegala et al., 2018). 
 
Tbx2 thus appears to suppress signaling through both the Activin/Nodal and BMP/GDF branches 
of the TGFβ pathway. In canonical TGFβ signaling, upon ligand binding, the TGFβ type II 
receptors phosphorylate the TGFβ type I receptors, which propagates the signal and 
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phosphorylates the carboxyl terminus of the intracellular signal transducers Smad1/5 or Smad2/3, 
downstream of BMP/GDF or Activin/Nodal ligands, respectively (Abdollah et al., 1997; Wrana et 
al., 1994). These receptor-mediated Smads then form a heteromeric complex with Smad4 which 
translocates to the nucleus where it associates with transcription factors to regulate gene expression 
(Abdollah et al., 1997).  
 
The discovery that Tbx2 has a global impact on TGFβ signaling prompted us to examine more 
directly the relationship between Tbx2 and components of the Activin/Nodal and BMP/GDF 
networks. Here we report that Tbx2 physically associates with both Smad1 and Smad2, essential 
intracellular mediators of BMP and Nodal signaling, respectively. Deletion analysis of the Tbx2 
protein identified the T-box DNA-binding domain as sufficient for Tbx2-Smad binding. Structure-
function analyses suggest a model in which Tbx2 regulates interaction of Smads and Smad-
interacting proteins in the nucleus.  
 
3.2 Results 
3.2.1 Tbx2 physically associates with multiple Smad proteins 
We have previously reported that Tbx2 inhibits mesoderm induction in animal cap explants treated 
with either basic Fibroblast Growth Factor (bFGF) or the TGFβ ligand Activin (Teegala et al., 
2018). We find that misexpression of Tbx2 also inhibits expression of the panmesodermal marker 
brachyury in ventral and dorsal marginal zone explants, indicating that Tbx2 represses mesoderm 
formation in the context of the embryo (Figure 3.1) (Smith et al., 1991). Notably, ventral marginal 
zone explants show an increase in the dorsal markers chordin and goosecoid and repression of the 
ventral marker wnt8, demonstrating that Tbx2 has a dorsalizing effect on the mesoderm, as well 
as the ectoderm (Cho et al., 1991; Christian et al., 1991; Sasai et al., 1994; Teegala et al., 2018) 
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(Figure 3.1). These and earlier published studies suggest that Tbx2 inhibits both Activin/Nodal 
and BMP/GDF signaling in the early embryo (Teegala et al., 2018). This raised the prospect that 
Tbx2 may inhibit TGFβ signaling via direct interaction with TGFβ signaling transducers. 
  
Figure 3-1 Tbx2 dorsalizes ventral mesoderm. 
RT-PCR analysis of marginal zone explants. Embryos were injected radially at early cleavage 




To address this possibility of direct interaction between Tbx2 and intracellular components of the 
TGFβ signaling network, we first examined whether Tbx2 physically associates with the Smad1 
and Smad2 proteins, branch-specific mediators of BMP/GDF and Activin/Nodal signaling, 
respectively. As we have not been able to obtain an antibody that recognizes native Tbx2, we 
generated a Myc-epitope-tagged Tbx2 construct (Myc-Tbx2), and injected myc-tbx2 synthetic 
RNA into early cleavage stage embryos. Immunoprecipitation and Western blot analysis 
demonstrate that native Smad1 physically associates with exogenous Tbx2 in Xenopus embryos 
(Figure 3.2 A). We have not been able to detect native Xenopus Smad2 following 
immunoprecipitation using commercially-available antibodies; thus, we next co-injected myc-tbx2 
and flag-smad2 synthetic RNA into early cleavage stage embryos. Physical association between 
exogenous Smad2 and Tbx2 in X. laevis embryos was observed (Figure 3.2 B). Tbx2 inhibits 
mesodermal marker gene expression stimulated by Smad2, consistent with a physiological role for 





Figure 3-2 Tbx2 associates with R-Smads. 
A) Tbx2 physically associates with Smad1. 1 ng myc-tbx2 RNA was injected at early cleavage 
stages. Pull-down of native Smad1 from injected embryos leads to co-immunoprecipitation of 
exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel studies as a negative control. 
B) Tbx2 physically associates with Smad2. 1ng of myc-tbx2 and 1ng of flag-smad2 were injected 
at early cleavage stages. Pull-down of Flag-Smad2 from injected embryos leads to co-
immunoprecipitation of exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel 
studies as a negative control C) Tbx2 represses Smad2-mediated mesoderm induction. Embryos 
were injected with tbx2 (1ng), flag-smad2 (1ng), or tbx2 (1ng) and flag-smad2 (1ng) at the two-
cell stage and animal caps were explanted at stage 8.5. Tbx2 represses Smad2-induced mesoderm. 
D) Tbx2 physically associates with Smad4. 1ng of myc-tbx2 and 1ng of flag-smad4 were injected 
at early cleavage stages. Pull-down of Flag-Smad4 from injected embryos leads to co-
immunoprecipitation of exogenous Tbx2. Normal rabbit IgG antibodies were used in parallel 





Following pathway-specific activation, both branches of the TGFβ pathway converge on the “co-
Smad” Smad4, which associates with C-terminally phosphorylated forms of both Smad1 and 
Smad2 (Lagna et al., 1996). As with Smad1 and Smad2, exogenous Tbx2 physically associates 
with Flag epitope-tagged human Smad4 (Figure 3.2 D). Taken together, these studies demonstrate 
that Tbx2 associates with both pathway-specific and pathway-shared Smad proteins. Additionally, 
these data indicate that Tbx2 is unlikely to inhibit TGFβ signaling via sequestration of R-Smads 
from Smad4. 
 
3.2.2  Identification of the Tbx2 domain sufficient for R-Smad association 
Our determination of interactions between Tbx2 and Smad proteins prompted us to ask whether 
these associations are central to Tbx2’s role in suppression of ventral and/or extraectodermal fate. 
To determine whether Tbx2 requires interaction with Smad1 and Smad2 to mediate dorsoventral 
patterning or mesendodermal suppression, respectively, we first sought to identify the domains of 
Tbx2 protein required for Smad interaction. Toward this end, we constructed multiple Tbx2 
deletion constructs, tagged with a Myc epitope (Figure 3.3). These deletion constructs were 
designed so that each construct lacks one or more domains of Tbx2, with the goal of eliminating 
the region necessary for R-Smad interaction. Following injection of RNA encoding these 
constructs, we performed immunoprecipitation assays using either a Smad1 antibody or, after co-
injection of myc-tbx2 and flag-smad2, a Flag epitope-specific antibody, followed by SDS-PAGE 
and Western blotting with an anti-Myc antibody. These studies identify the T-box region as 
sufficient for association with either Smad1 or Smad2; deletion of the N or C termini had no effect 
on R-Smad association. Tbx2 constructs with the first or second spacer deleted also associated 




Figure 3-3 Depictions of Myc-tagged Tbx2 deletion constructs 
“Myc” refers to a 6x Myc epitope tag. N and C refer to the N and C termini, respectively. S1 and 
S2 refer to the first and second spacer, respectively. 
 
Figure 3-4 The Tbx2 Spacer 1 and T-box domains are sufficient for R-Smad association. 
 A-E) Smad1 physically associates with Tbx2 via the T-box. Embryos were injected at the two-
cell stage with 1ng of RNA synthesized from the indicated deletion construct. Pull-down of native 
Smad1 from injected embryos leads to co-immunoprecipitation of the exogenous deletion 
construct. Normal rabbit IgG antibodies were used in parallel studies as a negative control. F-J) 
Smad2 physically associates with Tbx2 via the T-box. Embryos were injected at the two-cell stage 
with 1ng of RNA synthesized from the indicated deletion construct and flag-smad2. Pull-down of 
Flag-Smad2 from injected embryos leads to co-immunoprecipitation of the exogenous deletion 
construct. Normal rabbit IgG antibodies were used in parallel studies as a negative control. 
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3.2.3  Activity of deletion constructs 
Because the region of Smad association is within the T-box, we questioned whether the smallest 
construct that contained the T-box has activity. We expected this construct, Tbx2S1T, to function, 
if at all, like Tbx2ΔC as both lack a previously identified C-terminal repressor domain. Previous 
work from our lab showed that Tbx2ΔC does not repress Activin-mediated mesoderm expression 
(Teegala et al., 2018). To test the activity of Tbx2S1T, we used an embryological explant assay. 
Animal caps were explanted at stage 8.5 from embryos injected at the 2-cell stage with RNA 
transcribed from Tbx2S1T and cultured until stage 11 in the presence or absence of Activin. These 
samples were then assayed for mesodermal gene expression. To our surprise, this construct 
repressed Smad2/Activin-mediated mesoderm induction in animal caps, suggesting the presence 
of a second, previously unidentified repressor domain in Tbx2S1T (Figure 3.5 A). Unlike full-
length Tbx2, misexpression of this construct did not repress all ventral markers; Vent2 was not 
repressed, while repression of Szl was sometimes observed, indicating that complete ventral 
repression may require an as-yet undefined composite of domains (Figure 3.5 A, data not shown). 
Alternatively, it is possible that a higher concentration of tbx2S1T is required for ventral than for 






Figure 3-5 Effects of Tbx2 deletion constructs on the BMP/GDF and Activin/Nodal 
pathways.  
A) Embryos were injected with 2ng of tbx2 or tbx2S1T in the animal pole at the two-cell stage. 
Animal caps were explanted at stage 8.5. Activin was added (2.5ng/ml) as indicated. B) Embryos 
were injected with 2ng of tbx2 or tbx2NS1T in the animal pole at the two-cell stage. Animal caps 
were explanted at stage 8.5. Activin was added (2.5ng/ml) as indicated. C) Embryos were 
injected with 2ng of tbx2 or tbx2NS1T in the animal pole at the two-cell stage. Animal caps were 
explanted at stage 8.5. D) Embryos were injected with 1ng tbx2 or tbx2ΔN in the animal pole at 
the two-cell stage. Animal caps were explanted at stage 8.5. Activin was added (2.5ng/ml) as 
indicated E) Embryos were injected with 1ng tbx2 or tbx2TS2C in the animal pole at the two-cell 





This result led us to question why the presumed second Smad2/Activin repressor domain is not 
active in Tbx2ΔC. We hypothesize that there is a region present in Tbx2ΔC that functions as either 
an activator domain or an inhibitor of the second repressor domain. To test this possibility, we 
injected RNA transcribed from the construct missing both the C-terminus and the second spacer, 
Tbx2NS1T, into two-cell stage embryos. Animal caps were explanted at stage 8.5 and cultured in 
the presence or absence of Activin. Animal caps injected with tbx2NS1T RNA did not repress 
Activin-mediated mesoderm induction or ventral markers (Figure 3.5 B,C). These data supports 
our hypothesis, and indicates that the presence of the N-terminus inhibits activity of the repressor 
located in Tbx2S1T. Deletion of only the N-terminus has no effect on Tbx2 activity; animal caps 
explanted from embryos injected with RNA transcribed from Tbx2ΔN did not express mesodermal 
markers in the presence of Activin (Figure 3.5 D). Finally, RNA transcribed from Tbx2TS2C, was 
injected and assayed for activity. This construct functions like the full length Tbx2 in both the 
Smad1/BMP and Smad2/Activin pathways (Figure 3.5 E). These results indicate that a construct 
containing the T-box, second spacer, and C-terminus renders the N-terminus and the first spacer 
unnecessary for wild-type repression of both the Activin/Nodal and BMP/GDF pathways (Figure 
3.5 E). 
 
3.2.4 The Tbx2 nuclear localization sequence is necessary for Tbx2-Smad1 association 
Eomesodermin, a T-box transcription factor that physically associates with Smad2, is detected in 
both the nucleus and cytoplasm; we thus wondered whether Tbx2 associates with R-Smads in the 
plasma membrane (Picozzi et al., 2009). To explore this possibility, we removed the nuclear 
localization signal from the Myc-Tbx2S1T (Myc-Tbx2S1T-NoNLS) construct and injected myc-
Tbx2S1T-noNLS into early cleavage embryos. Upon pulldown with an anti-Smad1 antibody and 
subsequent western blot, no Myc-Tbx2S1T-NoNLS was detected (Figure 3.6 A). This suggests 
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that upon removal of the NLS, Myc-Tbx2S1T-NoNLS does not physically associate with Smad1. 
Additionally, removal of the nuclear localization signal renders Tbx2S1T inactive (Figure 3.6 B). 
Immunoprecipitation of Flag-Smad2 and subsequent Western blot analysis of embryos injected 
with 1ng of myc-Tbx2S1T-NoNLS and 1ng of flag-Smad2 demonstrates that Flag-Smad2 associates 
with Myc-Tbx2S1T-NoNLS (Figure 3.6 C). This suggests that Tbx2 associates with Flag-Smad2 
outside of the nucleus, however, it is possible that an abundance of exogenous Flag-Smad2 








Figure 3-6 Embryological activity and R-Smad association of Tbx2S1T-NoNLS.  
A) Tbx2S1T-NoNLS does not physically associate with Smad1. 1 ng myc-tbx2S1T-NoNLS RNA 
was injected at early cleavage stages. Pull-down of native Smad1 from injected embryos does not 
lead to co-immunoprecipitation of exogenous Tbx2S1T-NoNLS. Normal rabbit IgG antibodies 
were used in parallel studies as a negative control. B) Tbx2S1T-NoNLS does not repress 
mesodermal markers. Embryos were injected with 1ng of tbx2S1T-NoNLS at the two-cell stage and 
animal caps were explanted at stage 8.5 and incubated with Activin (2.5 ng/ml) as indicated. C) 
Tbx2S1T-NoNLS physically associates with Smad2. 1 ng myc-tbx2S1T-NoNLS and 1ng of flag-
Smad2 were injected at early cleavage stages. Pull-down of Flag-Smad2 from injected embryos 
leads to co-immunoprecipitation of exogenous Tbx2S1T-NoNLS. Normal rabbit IgG antibodies 






3.2.5 Tbx2 regulation of Smad C-terminal phosphorylation 
As mentioned above, TGFβ-induced nuclear accumulation and activation of Smad1 and Smad2 is 
mediated by phosphorylation of Serine residues at their C-termini (Macías-Silva et al., 1996). We 
reasoned that Tbx2 might inhibit Smad activation via inhibition of Smad C-terminal 
phosphorylation. To test this possibility, animal cap explants derived from embryos injected with 
tbx2 and cultured in the presence or absence of Activin were assayed at gastrula stages for 
embryological activity and for Smad C-terminal phosphorylation by Western blotting (Cell 
Signaling) (Simeoni and Gurdon, 2007). Uninjected embryos were processed in parallel. Notably, 
we found that Tbx2 does not decrease Smad2 phosphorylation levels in the presence of Activin, 
indicating that Tbx2 does not inhibit Activin/Nodal signaling through hypophosphorylation of 
Smad2 C-terminal Serine residues (Figure 3.7 A). Similar experiments were performed to examine 
the potential regulation by Tbx2 on Smad1 C-terminal phosphorylation. In these studies, Smad1 
C-terminal phosphorylation was similarly unaffected by the presence of ectopic Tbx2 (Figure 3.7 
B,C). These studies demonstrate that Tbx2 does not inhibit TGFβ signaling via C-terminal 





Figure 3-7 Tbx2 does not decrease levels of C-terminal phosphorylation of Smad1 and 
Smad2.  
A) Embryos were injected with 1ng tbx2 at the two-cell stage; animal caps were explanted at stage 
8.5 and incubated in Activin (2.5 ng/ml), as indicated, until late gastrula stages. Uninjected 
embryos were used in parallel studies. B) Embryos were injected with 1ng tbx2 at the two-cell 
stage and animal caps were explanted at stage 8.5 and incubated until late gastrula stages. 
Uninjected embryos were used in parallel studies. C) Quantification of data shown in B, indicating 




3.2.6 Tbx2 activity requires Arginine 122  
The T-box protein Tbx20 mediates repressor activity independent of DNA binding (Singh et al., 
2009). We therefore questioned whether DNA-binding was necessary for Tbx2 activity. We thus 
attempted to separate the DNA binding activity of Tbx2 from the physical association of Tbx2 
with R-Smads. Previous studies of T-box proteins have shown that Arginine 122 is necessary for 
Tbx2 DNA-binding activity (Sinha et al., 2000). An Arginine to Alanine mutation in the T-box of 
Myc-Tbx2 (Myc-Tbx2R-A) abolishes repressor activity in both the BMP/GDF and Activin/Nodal 
branches of the TGFβ pathway (Figure 3.8 A). Co-immunoprecipitaion experiments with Myc-
tagged Tbx2R-A, Smad1, and Smad2 show that Tbx2 associates with R-Smads even when DNA-
binding activity is abolished (Figure 3.8 B,C). These data indicate that Tbx2 physically associates 
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with R-Smads independent of DNA-binding, and that this interaction is not sufficient for 
repression of TGFβ signaling. 
   
 
Figure 3-8 DNA binding is necessary for Tbx2 repressor activity. 
A) RT-PCR analysis of animal cap explants injected with Tbx2 DNA binding mutant construct. 
Embryos were injected with 1ng myc-tbx2R-A or myc-tbx2 at the two-cell stage; animal caps were 
explanted at stage 8.5 and incubated in Activin (2.5 ng/ml) where indicated until late gastrula 
stages. B) Smad1 physically associates with Tbx2R-A. Embryos were injected at the two-cell stage 
with 1ng of RNA synthesized from Myc-Tbx2R-A. Pull-down of native Smad1 from injected 
embryos leads to co-immunoprecipitation of exogenous Myc-Tbx2R-A. Normal rabbit IgG 
antibodies was used in parallel studies as a negative control. C) Smad2 physically associates with 
Myc-Tbx2R-A. Embryos were injected at the two-cell stage with 1ng myc-tbx2R-A and 1 ng flag-
smad2. Pull-down of Flag-Smad2 from injected embryos leads to co-immunoprecipitation of 








3.2.7 Identification of Tbx2 direct targets 
As described above, we have shown that Tbx2 DNA-binding activity is necessary for Tbx2-
mediated gene repression (Figure 3.8A). To further define the direct targets to which Tbx2 binds, 
we utilized a pharmacological assay. Cycloheximide is a compound that interferes with translation 
elongation by inhibiting translocation of deacetylated tRNA during eukaryotic protein synthesis 
and is commonly used to identify direct targets of transcription factors (Engleka et al., 2001; 
Klinge et al., 2011; Obrig et al., 1971; Schneider-Poetsch et al., 2010). In the presence of 
cycloheximide, increases of gene expression of direct transcriptional targets only are observed; 
inhibition of translation of intermediary transactivators blocks increases in expression of indirect 
transcriptional target genes. . 
 
Because Tbx2 is a repressor, the overexpression of Tbx2 in the animal pole would not cause a 
notable change in gene expression in the presence of cycloheximide; the genes that Tbx2 is known 
to repress are not expressed in the ectoderm (Teegala et al., 2018). Therefore, to identify Tbx2 
target genes, we utilized a construct in which the DNA-binding domain of Tbx2 is fused to a VP16 
activation domain (Tbx2-DBD-VP16) (Teegala et al., 2018). Tbx2-DBD-VP16 functions as an 
activator and activates genes repressed by overexpression of Tbx2 (Teegala et al., 2018). Early 
cleavage embryos were injected with 1ng of tbx2-DBD-VP16 and animal caps were explanted at 
stage 8. These explants were incubated in the presence or absence of cycloheximide and harvested 
at early gastrula stages. Promoter analysis experiments suggest that Bix4 is a direct target of Tbx2; 
site-directed mutagenesis of multiple T-box sites on the Bix4 promoter inhibit Tbx2-mediated 
Bix4 repression, suggesting that Tbx2 represses Bix4 through multiple T-box sites on the Bix4 
promoter (Teegala et al., 2018). The cycloheximide-treated samples, along with control samples, 
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were assayed for expression of bix4 and other known T-box transcription factor targets derriere 
and wnt11 (Casey et al., 1999; Tada and Smith, 2000; White et al., 2002). As expected, Tbx2-
DBD-VP16 directly activates these target genes (Figure 3.9). In addition, wnt8, a ventral 
mesodermal marker repressed by Tbx2, is activated by Tbx2-DBD-VP16 in the presence of 
cycloheximde, suggesting that it is a direct target of Tbx2 (Figure 3.9). chordin activation by Tbx2-
DBD-VP16 is inhibited by cycloheximide, suggesting that it is an indirect target of Tbx2 (Figure 
3.9). Cycloheximide alone increases transcription of xbra and gsc; we therefore cannot determine 






   
Figure 3-9 Direct targets of Tbx2-DBD-VP16 
RT-PCR analysis of animal cap explants injected with tbx2-DBD-VP16. Embryos were injected 
with 1ng tbx2-DBD-VP16 at the two-cell stage; animal caps were explanted at stage 8 and 
incubated in cycloheximide (10 ug/ml), as indicated, until late gastrula stages. Cycloheximide 
alone is sufficient to increase expression of brachyury and goosecoid (Kurth et al., 2005; Tadano 







3.3 Discussion  
T-box transcription factors mediate cell specification and patterning in the early vertebrate embryo. 
Our results point to a central role for Tbx2-Smad interactions in the inhibition of both ventral and 
mesodermal fates. The inability of Tbx2S1T to consistently repress ventral markers, while 
effectively blocking mesoderm induction, indicates that different domains of Tbx2 may be 
necessary to repress the Activin/Nodal and BMP/GDF pathways. We find that the Tbx2 Spacer 1 
and T-box domains are sufficient for interaction with R-Smads. Because the T-box is necessary 
for Tbx2 activity, it was not possible to inhibit R-Smad association without eliminating a domain 
presumably required for DNA binding. A point mutation in the T-box of Tbx2 demonstrates that 
Tbx2 associates with R-Smads independently of DNA binding. Misexpression of the Tbx2 DNA-
binding mutant does not repress ventral or mesodermal markers, indicating that repression of 
ventral and mesodermal markers requires DNA binding. We have also identified several direct 
targets of Tbx2.  
In a previous study, we demonstrated that Tbx2 dorsalizes ectoderm and is necessary and sufficient 
for the suppression of mesoderm and endoderm in the animal pole of the gastrula stage X. laevis 
embryo (Teegala et al., 2018). Like Tbx2, several other repressors of mesodermal and ventral gene 
expression in the ectoderm function by inhibiting both the Activin/Nodal and BMP/GDF branches 
of the TGFβ signaling pathway (Bell et al., 2003; Casellas and Brivanlou, 1998; Xu et al., 2012). 
In the TGFβ signaling pathway, R-Smad proteins are present in the cytoplasm until they are 
phosphorylated following ligand receptor binding, and translocate into the nucleus (Macías-Silva 
et al., 1996). As knockdown of tbx2 in animal cap explants stimulates expression of mesodermal 
markers, it is possible that Tbx2 prevents low levels of phosphorylated R-Smads present in the 




 Various T-box transcription factors such as Eomesodermin, Brachyury, and Tbx20 have been 
shown to associate with either Smad1 or Smad2 and have been shown to function in either the 
BMP/GDF or Activin/Nodal pathways (Messenger et al., 2005; Picozzi et al., 2009; Singh et al., 
2009). Here, we describe a T-box protein that associates with both classes of R-Smad and that 
represses both branches of the TGFβ signaling network. The association between Brachyury and 
Smad1 requires BMP signaling and is necessary for the activation of Vent2.2 (Xom), a repressor 
of goosecoid (Messenger et al., 2005). If the association between Brachyury and Smad1 is 
attenuated, Brachyury activates goosecoid, and only high levels of both Brachyury and the BMP 
antagonist Noggin can activate goosecoid (Messenger et al., 2005). These results suggest that 
Brachyury activity is dependent on the level of BMP signaling and, subsequently, the levels of 
Smad1 in the nucleus. An analogous scenario possibly occurs in the presumptive ectoderm, 
whereby ventral Tbx2 activity is suppressed by high levels of nuclear Smad1.  
 
The domains of Smad1 and Smad2 necessary for Tbx2 association remain unknown. Brachyury, 
Eomesodermin, and Tbx20 have all been shown to physically associate with R-Smads (Messenger 
et al., 2005; Picozzi et al., 2009; Singh et al., 2009). To our knowledge, the R-Smad domain(s) 
necessary for the association with Eomesodermin and Tbx20 are not defined; Brachyury associates 
via its N-terminus with Smad1 via the Smad1 C-terminus (Messenger et al., 2005). Sequence 
analysis does not show any appreciable alignment between the N-terminus of Brachyury and any 
region of Tbx2. Additionally, unlike Tbx2, Brachyury does not associate with Smad2 (Messenger 




 T-box proteins have been shown to play an important role in a neuromesodermal bimodal “switch” 
to either promote mesodermal or neural gene expression at the expense of the other (Gentsch et 
al., 2013). The current study and previous data from our group show that Tbx2 promotes 
neuralization at the expense of a mesendodermal fate (Teegala et al., 2018). Our data suggest that 
Tbx2 may not inhibit R-Smad function directly; it is also possible that the Tbx2-Smad association 
is necessary for Tbx2 repressor activity in the context of germ layer differentiation. Many 
transcription factors that are responsible for controlling cell fate commitment in developing 
embryos also regulate development of pluripotent stem cells (Pei, 2009; Takahashi and Yamanaka, 
2006). Identifying transcription factors necessary for germ layer differentiation, including Tbx2, 




During gastrulation, T-box transcription factors play important roles in cell fate specification 
(Kofron et al., 1999; Smith et al., 1991; Teegala et al., 2018; Xanthos et al., 2001). For the first 
time, we show physical association between Tbx2 and intracellular mediators of both the 
BMP/GDF and Activin/Nodal signaling pathways. Protein-protein interaction assays indicate that 
the Tbx2 T-box is sufficient for association with R-Smads; furthermore, structure/function analysis 
identify a novel repressor domain in Tbx2 located in either the first spacer or the T-box. Inhibition 
of DNA binding by Tbx2 blocks its ability to inhibit ventral and mesodermal fate. Our studies 
suggest a model in which Tbx2 physically associates with Smad1 or Smad2, represses transcription 
of BMP/GDF or Activin/Nodal targets, and thus inhibits expression of ventral and mesodermal 




4 Chapter IV: Epigenetic mechanism of Tbx2 repression 
 
4.1 Background 
T-box proteins play an important role in the specification of cell fate. For example, Brachyury and 
Eomesodermin, T-box transcription factors present in the mesoderm, function as activators to 
specify a mesodermal cell fate (Picozzi et al., 2009; Smith et al., 1991). Recent work has shown 
that during gastrulation, T-box proteins also suppress inappropriate gene expression; Tbx2, a T-
box transcription factor, functions as a repressor in the ectoderm to suppress mesodermal, 
endodermal, and ventral gene expression (Reich et al., 2020; Teegala et al., 2018).  
 
During early development, ventral and mesendodermal gene expression is regulated largely by the 
BMP/GDF and Activin/Nodal branches of the TGFβ signaling pathway, respectively ((Howell and 
Hill, 1997; Schmidt et al., 1995; Wilson and Hemmati-Brivanlou, 1995). Previous studies have 
shown that mesodermal-specific T-box transcriptional activators physically associate with 
intracellular mediators of the TGFβ signaling pathway; in some studies, loss of this association 
results in aberrant T-box activity (Messenger et al., 2005; Picozzi et al., 2009). Recently, our lab 
showed that Tbx2 represses both the BMP/GDF and Activin/Nodal branches of the TGFβ signaling 
pathway, and physically associates with intracellular mediators of each branch (Reich et al., 2020; 
Teegala et al., 2018) (Chapter 3). However, the process through which Tbx2 functions to repress 
gene expression remains elusive. In the study described here, we attempt to identify the 
mechanisms through which Tbx2 mediates germ layer suppression. Immunoprecipitation and 
subsequent mass spectrometry, co-immunoprecipitation, and western blot analysis experiments 





4.2.1 Tbx2 physically associates with xH2A, xH2A.X, and xH2A.Z 
During gastrulation, Tbx2 functions downstream of multiple signaling pathways to repress 
inappropriate gene expression. Previous data has shown that Tbx2 represses Activin, FGF, and 
BMP- mediated gene expression (Figure 4.1) (Reich et al., 2020; Teegala et al., 2018).  
 
Protein-protein interaction assays, described above (Chapter 3), show that Tbx2 physically 
associates with intracellular mediators of the Activin/Nodal and BMP/GDF signaling pathways. 
However, these interactions are likely insufficient to explain the mechanism through which Tbx2 
represses signaling pathways independent from intracellular mediators of TFG signaling. 
Therefore, we sought to identify additional Tbx2-binding partners in order to further define the 






Figure 4-1 Tbx2 represses V-RAS-mediated mesoderm expression. 
A) RT-PCR analysis of animal cap explants injected with tbx2 and v-ras. Embryos were injected 
with 1ng tbx2, 40 pg v-ras, or 1ng tbx2 and 40 pg of v-ras at the two-cell stage; animal caps were 
explanted at stage 8.5 and incubated until late gastrula stages. 
 
To identify additional binding partners of Tbx2, we performed immunoprecipitations and 
subsequent mass spectrometry (IP-mass spec). As we have not been able to obtain an antibody that 
recognizes native Tbx2, we used a Myc-Tbx2 epitope-tagged vector (Myc-Tbx2), and injected 
myc-tbx2 synthetic RNA into early cleavage stage embryos. Embryos were collected at mid-
gastrulation and immunoprecipitated with an anti-Myc or control Mouse IgG1 antibody. The 
resulting immunoprecipitates were subjected to mass spectrometry. Histone 2A (H2A), a major 
component of chromatin structure, immunoprecipitated in the samples incubated with the anti-
Myc antibody. To confirm this association, we generated X. laevis Flag- and Ha-tagged H2A 
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constructs (FxH2A and HAxH2A). Immunoprecipitation and western blot analysis confirmed the 




Figure 4-2 Tbx2 physically associates with xH2A.  
A) 1 ng myc-tbx2 and 1 ng of ha-xH2A RNA were injected at early cleavage stages. Pull-down of 
Myc-Tbx2 from injected embryos leads to co-immunoprecipitation of exogenous xH2A. Normal 
Mouse IgG1 antibodies were used in a parallel study as a negative control. B) The reciprocal 
experiment of A. 1 ng myc-tbx2 and 1 ng of flag-xH2A RNA were injected at early cleavage stages. 
Pull-down of Flag-xH2A from injected embryos leads to co-immunoprecipitation of exogenous 
Tbx2. Normal Rabbit IgG antibodies were used in a parallel study as a negative control.  
  
































 Histone 2A is a component of the histone octamer nucleosome core around which an average of 
147 DNA base pairs are wrapped (Wood et al., 2005). The histone octamer plays a major role in 
regulating the accessibility of transcription factor binding sites (Walter et al., 1995). Post-
translational modifications to the structural “tails” of various Histones regulate the DNA-octamer 
association; modifications can sterically hinder or expose access to DNA cis-regulatory elements 
(Bowman and Poirier, 2015). In addition to the predominant form, several Histone 2A variants 
have been characterized (Bönisch and Hake, 2012). The most common variants of Histone 2A are 
Histone 2A.X (H2A.X) and Histone 2A.Z (H2A.Z). As both of these variants are expressed 
spatially and temporally in similar patterns to Tbx2, we examined whether Tbx2 can associate with 
one or both of these variants (Lee et al., 2010; Session et al., 2016; Shin et al., 2005). To determine 
whether Tbx2 can associate with these H2A variants, we generated Flag- and HA-tagged Histone 
2A variant constructs - H2A.X (FxH2A.X/HAxH2A.X) and H2A.Z (FxH2A.Z/HAxH2A.Z) . To 
test if Tbx2 associates with xH2A.X, 1 ng of myc-Tbx2 was injected with either 1ng of fxH2A.X 
or 1ng of HA-xH2A.X into early cleavage stage embryos. Immunoprecipitation and western blot 
analysis demonstrate that Tbx2 physically associates with xH2A.X (Figure 4.3 A,B). Using 
immunoprecipitation and western blot analysis, the association between Tbx2 and xH2A.Z was 





Figure 4-3 Tbx2 physically associates Histone 2A variants. 
A) Tbx2 physically associates with xH2A.X and xH2A.Z. 1ng of myc-tbx2 and 1ng of ha-
xH2A.X or ha-xH2A.Z were injected into early cleavage embryos. Pull-down of Myc-Tbx2 from 
injected embryos leads to co-immunoprecipitation of exogenous xH2A.X (lane 2) and xH2A.Z 
(lane 4). Normal Mouse IgG1 antibodies were used in a parallel study as a negative control. B) 
and C) Reciprocal experiments of Figure A. 1 ng myc-tbx2 and 1 ng of flag-xH2A.X (B) or 1 ng 
of flag-xH2A.Z (C) were injected at early cleavage stages. Pull-down of Flag-xH2A.X or Flag-
xH2A.Z from injected embryos leads to co-immunoprecipitation of exogenous Tbx2. Normal 
Rabbit IgG antibodies were used in a parallel study as a negative control. 
 
 


















































































































4.2.2 xH2A associates with R-Smads 
Because Tbx2 associates with both Smad1 and Smad2, we wondered whether Smad1 and Smad2 
also physically associate with xH2A (Reich et al., 2020). To address this possibility, 1ng of HA-
xH2A and 1ng of flag-Smad2 were injected into early cleavage stage embryos. Embryos were 
cultured until late gastrulation. Pulldown with an anti-Flag antibody and subsequent Western 
blotting shows that HA-xH2A physically associates with the Activin/Nodal--pathway specific R-
Smad, Smad2 (Figure 4.4 A, lanes 1 and 2). Like Smad2, the BMP specific R-Smad, Smad1, 
associates with HA-xH2A (Figure 4.4B). 
 
 
Figure 4-4 xH2A physically associates with R-Smads.  
A). 1ng of myc-Smad2 and 1ng of flag-xH2A (lanes 1 and 2), or 1ng of myc-Smad2, 1ng of flag-
xH2A, and 1ng of tbx2 (lanes 3 and 4) were injected into early cleavage embryos. Pull-down of 
Flag-xH2A from injected embryos leads to co-immunoprecipitation of exogenous Smad2 (lane 
2). Overexpression of tbx2 does not inhibit the association between xH2A and Smad2 (compare 
lanes 2 and 4) . Normal Rabbit IgG antibodies were used in a parallel study as a negative control. 
B) Smad1 physically associates with xH2A. 1 ng of flag-xH2A or was injected at early cleavage 
stages. Pull-down of endogenous Smad1 from injected embryos leads to co-immunoprecipitation 
of exogenous xH2A. Normal Rabbit IgG antibodies were used in a parallel study as a negative 
control. 
  









































Because previous data show that Tbx2 physically associates with R-Smads, and here we show that 
R-Smads associate with xH2A, we wondered whether overexpression of Tbx2 inhibits the 
association between R-Smads and xH2A. To test this, early cleavage stage embryos were injected 
with 1ng of myc-Smad2, 1ng of fxH2A, and 2ng of tbx2. Immunoprecipitation and western blot 
analysis show no difference in the level of association between Smad2 and FxH2A when Tbx2 is 
overexpressed in the animal pole compared with embryos injected with only myc-Smad2 and 
fxH2A. (Figure 4.4 A, compare lanes 2 and 4).  
 
4.2.3 The first spacer and T-box are sufficient for Tbx2/xH2A association 
To determine if the Tbx2/Histone 2A association is necessary for Tbx2-mediated germ layer 
suppression, we attempted to separate the physical association between Tbx2 and Histone 2A and 
the repressor activity of Tbx2. Tbx2S1T is the smallest constructed deletion construct that represses 
mesodermal markers. If Histone 2A does not associate with this construct, it would suggest that a 
physical association between Histone 2A and Tbx2 is not necessary for Tbx2S1T-mediated 
mesodermal repression. To test this, we co-injected flag-hH2A and myc-Tbx2S1T into early 
cleavage X. laevis embryos. Immunoprecipitation and Western blot analysis show a physical 





         
Figure 4-5 Tbx2S1T and Tbx2R-A associate with hH2A.  
A) Tbx2R-A physically associates with xH2A. 1 ng myc-tbx2R-A and 1 ng of flag-xH2A RNA 
was injected into the animal pole at early cleavage stages. Pull-down of Flag-xH2A from 
injected embryos leads to co-immunoprecipitation of exogenous Myc-Tbx2R-A. Normal Rabbit 
antibodies were used in a parallel study as a negative control. B) Tbx2S1T physically associates 
with xH2A. 1 ng myc-tbx2S1T and 1 ng of flag-xH2A RNA were injected into the animal pole at 
early cleavage stages. Pull-down of Flag-xH2A from injected embryos co-immunoprecipitates 
exogenous Myc-Tbx2S1T. Normal Rabbit antibodies were used in a parallel study as a negative 
control 
4.2.4 A Tbx2 DNA-binding mutant physically associates with xH2A 
T-box proteins are well-characterized as transcription factors; we thus wondered if Tbx2 DNA 
binding is necessary for Tbx2-xH2A association. To determine this, we used the Tbx2 DNA-
binding mutant mentioned previously in protein-protein interaction experiments. During early 
cleavage stages, 1ng of myc-Tbx2R-A and 1ng of flag-hH2A were injected into the animal pole. 
Embryos were harvested at mid-to-late gastrula stages. Immunoprecipitation and Western blot 








The eukaryotic genome is organized into chromatin which allows it to fit into the nucleus. This 
chromatin structure is composed of nucleosomes which consist of DNA wrapped around histone 
octamers. These octamers are composed of two Histone 2As, two Histone 2Bs, 2 Histone 3s, and 
2 Histone 4s (Bönisch and Hake, 2012). Histone modifications manipulate the chromatin structure 
and can make DNA more or less accessible during a number of important of biological processes 
such as DNA replication, DNA repair, transcriptional regulation, and genome stability (Bhaumik 
et al., 2007). Histone 2A variants are variants of the canonical Histone 2A and contribute to 
chromatin complexity. Histone 2A can be replaced with a Histone 2A variant, which has a 
profound effect on the biological outcome. Amino acid sequences of the Histone 2A variants are 
most divergent near their C-termini, where most Histone modifications occur (Bönisch and Hake, 
2012). There are many identified Histone 2A variants. The two variants considered “universal,” 
found in almost every organism examined, are H2A.X and H2A.Z (Bönisch and Hake, 2012). 
Here, we show that Tbx2 and R-Smads physically associates with xH2A, and that Tbx2 also 
associates with the universal H2A variants, H2A.X and H2A.Z.  
 
The domain of Tbx2 necessary for the Tbx2-H2A association is located in the first spacer and/or 
T-box of Tbx2. This construct designed to include these regions, Tbx2S1T, contains a repressor 
domain; overexpression of tbx2S1T is sufficient to repress mesodermal but not ventral gene 
expression (Figure 3.5 A) (Reich et al., 2020). This suggests that the association alone between 
Tbx2 and H2A is not sufficient for repression of ventral gene expression. Additionally, the Tbx2 
DNA-binding mutant, Tbx2R-A, binds both Smad1 and Smad2, but does not repress either 
mesodermal or ventral gene expression (Reich et al., 2020). Here we show that Tbx2R-A 
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associates with H2A, again suggesting that the Tbx2-H2A protein interaction is not sufficient for 
Tbx2 repressor activity.  
 
As xH2A is a component of the Histone octamer, it is possible that Tbx2 associates indirectly with 
xH2A and directly with either a different Histone, or a Histone/chromatin-modifying protein. 
Many previously identified Histone-modifying proteins play a crucial role in germ layer 
patterning. For example, the Polycomb Repressor Complex 2 (PRC2) trimethylates H3K27 to 
silence gene expression and maintain cell fate identity. (Laugesen et al., 2016). Previous studies 
show that Tbx3, a T-box protein that can function as an activator of endodermal gene expression, 
physically associates with the histone demethyltransferase, JMJD3 (Kartikasari et al., 2013). 
During endodermal differentiation, Tbx3 recruits JMJD3 to the promoter region where JMJD3 
demethylates H3K27 to activate gene expression (Kartikasari et al., 2013). Planned studies in our 
lab include protein-protein association assays to determine whether Tbx2 physically associates 




Many T-box transcription factors have been shown to play important roles in pluripotency and cell 
fate determination during gastrulation. Our previous studies suggest a model in which Tbx2 
physically associates with Smad1 or Smad2, represses transcription of BMP/GDF or 
Activin/Nodal targets, and thus inhibits expression of ventral and mesodermal genes, respectively 
(Reich et al., 2020). The studies described in this chapter suggest that Tbx2 uses an epigenetic 
mechanism to repress gene expression. We show that Tbx2 can physically associate with xH2A, 
xH2A.X, and xH2A.Z. The physical association between Tbx2 and R-Smads, R-Smads and xH2A, 
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and Tbx2 and xH2A, suggests a model in which Tbx2 is a component in a complex that includes 
R-Smads and xH2A. Future work will explore additional chromatin modifying binding partners of 
Tbx2 in an attempt to further characterize the function of Tbx2.
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5 Chapter V: Conclusion and future directions 
 
During vertebrate development, the formation and patterning of the three germ layers is a rapid 
and tightly regulated process; studies in the frog X. laevis have been essential for our 
understanding of these processes. An initiating step in development of the germ layers occurs when 
VegT, a maternally supplied transcription factor, directly initiates an endoderm-specific gene 
expression program among cells located in the vegetal pole (Horb and Thomsen, 1997). VegT also 
activates nodal and nodal-related gene expression; these transcripts encode proteins that induce 
cells in the region adjacent to the vegetal pole, in the so-called marginal zone, to differentiate into 
mesoderm (Kofron et al., 1999; Xanthos et al., 2001). In this VegT-centric model of germ layer 
formation, differentiation in the animal pole is the consequence of an absence of both extracellular 
signaling and germ layer-specific transcriptional activation -- VegT is not expressed in this region, 
and it is far from the source of Nodal signaling; thus, neither endodermal nor mesodermal 
differentiation ensues, and ectoderm forms in the animal pole “by default” (Heasman, 2006; 
Hemmati-Brivanlou and Melton, 1994). 
Recently, however, it has become clear that the suppression of inappropriate cell fate also plays a 
critical role in germ layer determination in the vertebrate embryo (Reich and Weinstein, 2019). 
The BMP branch of the TGFβ signaling pathway regulates ventral/dorsal patterning in the 
ectoderm during gastrulation; high levels of BMP signaling are present on the ventral side of the 
ectoderm, while low levels of BMP signaling are present in the dorsal side of the ectoderm 
(Simeoni and Gurdon, 2007; Weinstein and Hemmati-Brivanlou, 1997). The absence of TGFβ 
signaling in the dorsal ectoderm gives rise to what is considered the “default” state of the ectoderm- 
neural tissue (Weinstein and Hemmati-Brivanlou, 1997). Recent studies have shown that not only 
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is the absence of induction necessary for the default neural fate to differentiate, but several proteins 
present in the ectoderm are required for the repression of mesoderm/endodermal gene expression 
in the ectoderm during gastrulation (Reich and Weinstein, 2019). This thesis describes one such 
factor: Tbx2, a T-box transcription factor present in the animal pole during gastrulation, Tbx2, has 
been shown to be necessary for endodermal and mesodermal gene repression in the ectoderm.  
 
The work presented in this thesis suggests a model that begins to elucidate the mechanisms through 
which Tbx2 functions to repress gene expression. Embryological and protein-protein assays show 
that Tbx2 physically associates with both Smad1 and Smad2, and represses Smad1- and Smad2- 
mediated gene expression; namely ventral- and mesodermal-specific genes (Figure 5.1 B). We 
determine here that the Tbx2 deletion construct Tbx2S1T is sufficient to associate with R-Smads, 
and that this construct contains a previously unidentified repressor domain. Overexpression of 
tbx2S1T is sufficient to repress mesodermal genes and insufficient to repress ventral markers, 
suggesting that the mechanism through which Tbx2 represses the Activin/Nodal pathway may 
differ from the mechanism though which Tbx2 represses the BMP/GDF branch of the TGFβ 
signaling pathway. Additionally, we show that a Tbx2 DNA-binding mutant associates with R-
Smads, suggesting that Tbx2-R-Smad association is independent from the ability of Tbx2 to bind 
DNA. 
The Tbx2-R-Smad association identified in this thesis has not been shown to be necessary for 
Tbx2-mediated transcriptional repression. In order to determine if this association is necessary for 
Tbx2 activity, we will attempt to separate the R-Smad association from DNA-binding activity. In 
order to accomplish this, several successively smaller deletion constructs of the Tbx2 T-box will 
be constructed and assayed for R-Smad association and DNA-binding activity. If removal of the 
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amino acid sequence required for R-Smad association abolishes repressor activity while DNA-










Figure 5-1 Model of protein-protein interactions. 
A) Simplified model of the Activin/Nodal and BMP/GDF branches of the TGFβ signaling 






Because Tbx2 represses genes activated by the FGF, BMP/GDF, and Activin/Nodal pathways, we 
attempted to identify a chromatin-modifying binding partners that might function downstream of 
multiple pathways. IP-Mass spectrometry identified Histone 2A as a binding partner of Tbx2. Co-
immunoprecipitation experiments suggest a model in which Tbx2, H2A, and R-Smads form a 
complex. Future experiments will continue to identify binding partners of Tbx2 in order to fully 
characterize the mechanism through which Tbx2 represses inappropriate gene expression. 
 
The protein-protein interaction assays described above demonstrate that Tbx2 physically 
associates with Histone 2A. It is well established that histone modifications play an important role 
in gene regulation. For example, trimethylation of Histone 3 lysine 27 silences gene expression 
(Wiles and Selker, 2017). A common modification of Histone 2A is the ubiquitination of Lysine 
119 (H2AK119u1) on the histone tail (Wang et al., 2004). Ring1 and Ring1B are E3 ubiquitin 
ligases (Zhou et al., 2008). These Ring family ubiquitin ligases are the catalytic components of the 
Polycomb Repressive Complex 1 that mediate deposition of ubiquitin on Histone 2A. Mono-
ubiquitination is most commonly associated with transcriptional repression. Histone 2A mono-
ubiquitination represses transcription by preventing the release of RNA polymerase, stunting 
elongation (Dellino et al., 2004). In X. laevis, knockdown of USP-12, a Histone 2A deubiquitinase, 
in whole embryos during early development leads to a reduction of mesoderm-specific gene 
expression (Joo et al., 2011). This suggests that Ring1-mediated monoubiquitination of H2AK119 
may repress the transcription of mesodermal genes. Further experiments are needed to determine 
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